ArticleEuropean journal of hospital pharmacy : science and practice2017
Impact of medication review, within a shared decision-making framework, on deprescribing in people living in care homes.
Article in European journal of hospital pharmacy : science and practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Pooled it
- Supporting shared decision making for older people with multiple health and social care needs: a realist synthesis.BMC geriatrics · 2018Pooled it
- Perioperative Depression and Anxiety Care in Older Patients: A Randomized Clinical Trial.JAMA network open · 2026Trial
- Impact of structured medication reviews on prescribing in English primary care: a retrospective observational cohort study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026Observational
- Service delivery and the role of clinical pharmacists in UK primary care for older people, including people with dementia: a scoping review.BMC primary care · 2025Article
- Pharmacist-Mediated Deprescribing in Long-Term Care Facilities: A Systematic Review.Pharmacy (Basel, Switzerland) · 2025Review
- Prescribing Appropriate Medicines to Older Adults: A Finnish Experience with the Web-Based Meds75+ Database.Drugs & aging · 2024Review
- Article
- An integrative systematic review of nurses' involvement in medication deprescription in long-term healthcare settings for older people.Therapeutic advances in drug safety · 2024Review
- Deprescribing, shared decision-making, and older people: perspectives in primary care.Journal of pharmaceutical policy and practice · 2023Review
- Pharmacy professionals' perceptions of educational supervision in primary care through the lens of Proctor's model.BMC medical education · 2023Article
- The role of on-site pharmacist in residential aged care facilities: findings from the PiRACF study.Journal of pharmaceutical policy and practice · 2023Article
- Article
- General practitioners' role in improving health care in care homes: a realist review.Family practice · 2023Review
- Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.Health & social care in the community · 2022Article
- Educational supervision to support pharmacy professionals' learning and practice of advanced roles.International journal of clinical pharmacy · 2022Article
- How Do Pharmacists Practice in Aged Care? A Narrative Review of Models from Australia, England, and the United States of America.International journal of environmental research and public health · 2021Review
- Article
- The Contribution of Pharmacists and Pharmacy Technicians to Person-Centred Care within a Medicine's Optimisation in Care Homes Service: A Qualitative Evaluation.Pharmacy (Basel, Switzerland) · 2021Article
- Physicians', Nurses' and Pharmacists' Perceptions of Determinants to Deprescribing in Nursing Homes Considering Three Levels of Action: A Qualitative Study.Pharmacy (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe key objectives of this study were to quantify extent of prescribing, reasons for deprescribing, common therapeutic groups of medicines deprescribed and adverse events.
methodsA retrospective analysis was carried out on a quality improvement project where 422 care home residents in 20 care homes received a medicines optimisation review with a pharmacist and other members of the healthcare team (general medical practitioner, care home nurse). Data on number, type and cost of medicines were collected. Statistical analysis was performed to test for differences between pharmacist-only review and the pharmacist plus general practitioner (GP), and to identify any correlation between the original number of medicines and the number of medicines stopped.
resultsOf the 422 patients reviewed, 298 (70.6%) had at least one medicine stopped with 704 medicines being stopped. This represented 19.5% of the medicines originally prescribed (3602 medicines). There was no statistically significant difference between pharmacist only and pharmacist plus GP in terms of stopping medicines. The main groups of medicines stopped were laxatives, skin products and bone protection. There was weak correlation between the original number of medicines prescribed and the number stopped.
conclusionsThis study has shown that medicines optimisation reviews can lead to a reduction in polypharmacy for care home residents through a deprescribing process. Patients' medicine regimens were simplified and optimised while making financial significant savings for the National Health Service.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.